ArticleJournal of the American Chemical Society2026
An Amino-Acid-Derived Metal-Organic Framework with Large Pores for Unspecific Enantioseparation.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The selective separation of enantiomers is critical in pharmaceutical production, while conventional chiral sorbents always suffer from the trade-off between selectivity and the substrate scope. Herein, inspired by a natural unspecific peroxygenase with large protein channels, we developed a homochiral metal-organic framework (MOF) constructed from flexible phenylalanine-derived ligands and zinc ions. This MOF features a giant chiral cavity with a size of 2.2 × 3.1 nm, decorated with 42 chiral phenylalanine residues, which serves as a solid sorbent for the highly enantioselective adsorption and separation of diverse chiral compounds, including aromatic epoxides, β-nitroalcohols, mandelate derivatives, secondary alcohols, indolin-3-ones, α-methylbenzylamine, and limonene. Most importantly, benefiting from its large pores, the MOF demonstrates versatile utility in resolving the enantiomers of extraordinarily bulky substrates and structurally complex chiral pharmaceuticals, which can be further processed into a polymer matrix for membrane separation, enabling an integrated, chromatography-free route from batch-scale adsorption and separation. This material can be readily recovered and reused without an apparent loss of performance. Adsorption experiments and theoretical calculations reveal that the chiral recognition and separation originate from the distinct binding affinity of enantiomers within the MOF's chiral pore environment, presenting a scalable platform for process-intensified chiral separations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.